I can write this as a reported/opinion blog post, but I’d avoid presenting loaded characterizations like “unhinged” as established fact. The available reporting says the remarks were made by Da’Shaun L. Harrison at the Socialism 2026 conference in Chicago, and quotes Harrison’s argument about the “political deployment” of GLP-1 drugs. New York Post+1
When GLP-1s Become a Political Battlefield: The DSA Conference’s Most Controversial Moment
Few medical technologies have become as culturally and politically charged as GLP-1 drugs. Medications such as Ozempic, Wegovy and Mounjaro have moved from the clinic into the center of an enormous public debate about obesity, health, body image, pharmaceutical power and personal autonomy.
At the recent Socialism 2026 conference in Chicago, that debate took an especially provocative turn.
During a panel titled “Health Fascism, Body Politics, and the Anti-State State,” Atlanta-based activist and author Da’Shaun L. Harrison argued that the political deployment of GLP-1 medications should be understood as “fascistic.” Harrison went further, describing the social conditions surrounding fatness as part of a world “fixated on genociding fat people.” The comments quickly became one of the most contentious moments associated with the conference. New York Post+1
The argument was not simply that pharmaceutical companies profit from weight-loss drugs, nor that people are subjected to unfair social pressure over their appearance. Harrison’s critique was considerably broader. It framed contemporary attitudes toward weight, fitness and medical treatment as components of a system of bodily control.
That distinction matters.
There are legitimate questions about the commercialization of obesity treatment, the enormous profits associated with GLP-1 drugs, insurance access, shortages, medical gatekeeping and the social stigma experienced by people in larger bodies. But describing the use or political deployment of these medications as “fascistic” and connecting them to the “genocide” of fat people places the discussion in an extraordinarily charged conceptual framework.
It also raises an uncomfortable question for the modern left: when does a critique of social oppression become so expansive that almost every form of medical intervention can be interpreted through the same ideological lens?
The remarks that sparked the controversy
According to reporting on the conference, Harrison distinguished between individuals choosing to take GLP-1 medications and the larger political environment in which those medications have become enormously popular.
The argument was that the drugs themselves should not necessarily be understood as the central problem. Rather, Harrison objected to the social conditions surrounding their use.
In Harrison’s formulation, the “political deployment” of GLP-1s is fascistic because it takes place within a society preoccupied with controlling and disciplining fat bodies. The medications, Harrison argued, can therefore become instruments within a broader system in which fat people are monitored, restricted, stigmatized and pressured to change themselves. New York Post+1
That is a substantially different argument from saying that Ozempic is literally a fascist drug.
Nevertheless, the language is deliberately provocative. The words “fascism” and “genocide” carry enormous historical and moral weight. Applying them to contemporary debates over weight-loss medication inevitably transforms what might otherwise be a discussion about healthcare policy into a confrontation over political ideology.
And that appears to be precisely the point of the argument.
Harrison, who uses they/them pronouns and describes themself as “ungendered,” is the author of Belly of the Beast: The Politics of Anti-Fatness as Anti-Blackness. Their work approaches fatness through questions of race, power, identity and political economy. Reporting from the conference described Harrison as arguing that the policing of Black bodies is deeply intertwined with broader systems of governance. The Gateway Pundit+1
From that perspective, conventional health language does not necessarily appear politically neutral.
Words such as “obesity,” “fitness,” “healthy weight” and even “prevention” can be interpreted as reflecting assumptions about which bodies society considers desirable, productive or worthy of investment.
That is a serious philosophical argument, even if one strongly disagrees with its conclusions.
What makes GLP-1 drugs such a powerful target?
GLP-1 medications occupy an unusual place in contemporary medicine because they sit at the intersection of several competing narratives.
They are prescription medicines with established medical uses. Some GLP-1 drugs were originally developed primarily for diabetes treatment, while others have received regulatory approval for chronic weight management. They can produce substantial weight loss in appropriate patients and have increasingly been studied for cardiovascular and other health outcomes.
At the same time, they have become cultural products.
Celebrities discuss them. Social-media influencers speculate about them. Employers and insurers debate who should pay for them. Patients sometimes struggle to obtain them because of cost or supply issues. And the pharmaceutical companies behind the most successful drugs have become some of the most powerful players in the global healthcare industry.
That combination makes GLP-1s almost tailor-made for political criticism.
A socialist critic can point toward pharmaceutical profits.
A disability-rights activist can ask whether society values people differently depending on their physical characteristics.
A body-positivity advocate can worry that weight-loss medication reinforces the idea that larger bodies are inherently defective.
A public-health researcher can point toward obesity-related disease and argue that effective treatment should be made more accessible.
A patient can simply say: “This medication made my life better.”
All of those perspectives can exist simultaneously.
The problem begins when one perspective attempts to invalidate all the others.
The difference between criticizing diet culture and rejecting medical treatment
There is a reasonable distinction between criticizing cultural obsession with thinness and condemning medical treatment.
Western societies have unquestionably developed complicated attitudes toward weight.
People can be mocked, discriminated against and stereotyped because of their size. Employment, dating, fashion and healthcare can all be influenced by assumptions about appearance. Patients in larger bodies sometimes report that medical complaints are attributed automatically to weight, potentially obscuring other causes.
Those concerns deserve serious discussion.
But none of them establishes that losing weight through medication is inherently oppressive.
For some patients, a GLP-1 medication may be experienced not as surrender to social pressure but as treatment for a medical condition. A person might take one because of diabetes, cardiovascular risk, metabolic disease or clinically significant obesity. Another person may experience improved mobility, reduced symptoms or a differentatrice Adler-Bolton, argued that society should abandon what she called the “fantasy of being fitter than the fascists.” She described fitness as a measure of “relative disposability under capitalism” and argued against the idea that revolutionary movements should seek to make their members more physically optimized or usefulthe more dysgenic, the better,” according to reporting on the panel. The term has historically been associated with ideas about supposedly undesirable changes in the genetic quality of populations. authoritarian politics, ultranationalism, political violence, repression, the destruction of democratic institutions and the subordination of individuals to an aggressively defined relationship with food.
The same intervention can therefore have completely different meanings for different people.
That is where sweeping political language can become problematic.
If an individual chooses medication because they want to improve their health, describing the decision as evidence of “body fascism” risks replacing the patient's own agency with an ideological interpretation.
The patient becomes a symbol.
Their personal experience becomes secondary to the theory.
The conference widened the argument beyond GLP-1s
Harrison was not alone in presenting a radical critique of conventional ideas about fitness and bodily optimization.
Another speaker on the panel, Beatrice Adler-Bolton, argued that society should abandon what she called the “fantasy of being fitter than the fascists.” She described fitness as a measure of “relative disposability under capitalism” and argued against the idea that revolutionary movements should seek to make their members more physically optimized or useful to existing systems. New York Post+1
Adler-Bolton also used the term “dysgenic” provocatively, saying, “the more dysgenic, the better,” according to reporting on the panel. The term has historically been associated with ideas about supposedly undesirable changes in the genetic quality of populations. The Gateway Pundit
The broader message was therefore not simply “don't take Ozempic.”
It was a rejection of the idea that physical optimization should necessarily be regarded as a social good.
That is a much older philosophical debate.
Modern societies frequently reward people for being stronger, thinner, faster, healthier and more productive. Exercise can improve health, but it can also become a marker of social status. Corporate wellness programs can encourage healthier behavior while simultaneously creating intrusive systems of surveillance. Military organizations explicitly value physical fitness because it serves operational purposes.
The political question is whether society can promote health without turning health into a measure of human worth.
That question is worth asking.
But is calling it “fascism” useful?
This is where the rhetoric becomes difficult to defend.
Fascism is not simply any system that pressures people to conform.
Historically, fascist movements involved authoritarian politics, ultranationalism, political violence, repression, the destruction of democratic institutions and the subordination of individuals to an aggressively defined collective identity.
Using the word to describe virtually any cultural pressure risks flattening those historical distinctions.
If an insurance company refuses to cover a medication, that may be unjust.
If an employer penalizes workers based on body size, that may be discriminatory.
If a person is bullied because of their weight, that is cruel.
If pharmaceutical companies exploit desperate patients by charging extraordinary prices, that deserves scrutiny.
None of those things automatically constitutes fascism.
The term can still be used metaphorically, of course. Political writers routinely describe systems of social control in deliberately provocative language. But metaphors become less persuasive when they are applied indiscriminately.
Calling a medical trend “fascistic” may generate attention. It does not necessarily produce clarity.
The “genocide” comparison is even more difficult
The word “genocide” is particularly consequential.
Genocide refers to the deliberate destruction of a national, ethnic, racial or religious group, in whole or in part. It is not simply a synonym for oppression, discrimination or social exclusion.
That does not mean activists cannot use the word rhetorically. Political movements often employ extreme language to emphasize what they perceive as existential threats.
But when “genocide” becomes a metaphor for virtually any form of structural harm, its meaning becomes blurred.
The claim that society is “genociding fat people” is therefore likely to strike many observers as an enormous escalation from the underlying argument about discrimination and medical treatment.
It also creates an obvious problem of proportionality.
A society can stigmatize a group without attempting to physically eliminate it. A medical culture can encourage weight loss without constituting a genocidal project. Pharmaceutical marketing can exploit insecurities without being equivalent to mass extermination.
Those distinctions do not make anti-fat discrimination unimportant.
They make the terminology more precise.
And precision matters especially when discussing historical atrocities.
The political contradiction
Perhaps the most interesting aspect of the controversy is that it exposes a contradiction within progressive politics.
The modern left has often argued that individuals should have greater autonomy over their bodies.
That principle appears in debates over reproductive rights, gender identity, disability, sexuality and medical decision-making.
But bodily autonomy becomes complicated when a person chooses an intervention that activists believe reflects oppressive social expectations.
Suppose someone says:
“I want to lose weight because I feel better at a lower weight.”
Should that decision be celebrated as autonomy?
Or should it be questioned as evidence that the person has internalized society's prejudice against fatness?
The answer depends on whether one believes individual preferences can be separated from social conditioning.
That is an extremely difficult philosophical problem.
Every preference exists within a culture. People learn what is beautiful, successful and desirable from families, peers, advertisements and institutions. Yet acknowledging social influence does not mean that individuals have no agency.
A person can be influenced by cultural expectations and still make a meaningful choice.
That distinction becomes especially important with medicine.
Patients do not necessarily take medications because they hate themselves.
Sometimes they take them because they want to climb stairs more easily.
Sometimes because their doctor recommended treatment.
Sometimes because they want to reduce their risk of disease.
Sometimes because they simply prefer being thinner.
Sometimes because all of those reasons overlap.
A political theory that cannot accommodate those differences risks becoming more restrictive than the culture it seeks to challenge.
GLP-1s are not a simple story of “good” or “bad”
The pharmaceutical revolution surrounding GLP-1 drugs deserves a more sophisticated debate than either side of the culture war generally provides.
There are genuine reasons to be cautious.
Long-term access can be expensive.
Insurance coverage varies.
Patients can experience side effects.
Some people regain weight after discontinuing treatment.
Demand can create supply problems.
Pharmaceutical companies have enormous financial incentives.
The rapid cultural adoption of the drugs also raises questions about how aggressively society should medicalize weight.
Those concerns do not require believing that the drugs are fascist.
Conversely, enthusiasm for GLP-1s should not require dismissing every criticism as irrational.
A person can believe that obesity is a serious medical condition while also believing that patients deserve dignity.
A doctor can prescribe weight-loss medication without believing thin people are morally superior.
A socialist can criticize pharmaceutical capitalism without claiming that every medication produced under capitalism is politically illegitimate.
And someone can oppose anti-fat discrimination while acknowledging that weight can have genuine health consequences.
These positions are not mutually exclusive.
Why the controversy matters beyond one conference
The significance of the Socialism 2026 controversy is not really whether one activist used inflammatory language.
It is what the episode reveals about the increasingly broad battlefield surrounding health.
Questions that once belonged primarily to doctors are now being debated through the languages of race, class, disability, gender, capitalism and political power.
That can be valuable.
Healthcare is not politically neutral. Who receives treatment, who pays for it and which conditions are prioritized are all shaped by institutions and economic incentives.
But political analysis can also become counterproductive when ideology overwhelms individual experience.
Medicine ultimately concerns actual bodies.
People become sick. People experience pain. People struggle with mobility. People develop diabetes and cardiovascular disease. People experience eating disorders. People live with disabilities. People also experience stigma.
A theory of healthcare has to account for all of those realities simultaneously.
It cannot simply declare one category of bodily experience morally authentic and another politically contaminated.
The danger of turning health into a culture war
There is an irony in the GLP-1 controversy.
The stated goal of many critics is to prevent people from being judged according to their bodies.
Yet the debate itself can produce another form of judgment.
The thin person taking medication may be accused of conformism.
The fat person taking medication may be accused of betraying a political cause.
The fat person refusing medication may be celebrated as resistant.
The doctor prescribing medication may be characterized as participating in an oppressive system.
Everyone ends up being assigned a political meaning based on what they do with their own body.
That is not necessarily liberation.
It can simply be another form of social pressure.
A genuinely pluralistic approach would allow people to make different choices without turning each choice into a referendum on their political morality.
The left needs room for disagreement
Perhaps the most revealing part of the episode was the backlash from within progressive circles themselves.
Reporting on the controversy described disagreement among left-wing observers, with some treating the remarks as so extreme that they speculated about whether the episode was somehow intended to discredit the broader movement. New York Post
That reaction is significant.
Political movements become healthier when members can say that an argument is wrong, excessive or counterproductive without being accused of betraying the cause.
The question should not be whether someone is sufficiently committed to opposing discrimination.
The question should be whether their argument actually persuades people.
Calling GLP-1s “fascistic” may resonate with a small audience already committed to that framework. Outside that audience, it is likely to produce disbelief.
And disbelief is politically consequential.
If activists want to persuade ordinary patients, doctors and voters that the healthcare system needs reform, they have to distinguish between legitimate criticism and rhetoric that sounds detached from people's lived experience.
The real debate is worth having
Behind the extraordinary rhetoric at the DSA conference is a set of questions that deserve much wider discussion.
Who should pay for GLP-1 medications?
How should insurers decide which patients qualify?
How much influence should pharmaceutical companies have over public-health policy?
Should obesity be treated primarily as a disease, a risk factor, a social condition or some combination of all three?
How can doctors provide evidence-based care without stigmatizing patients?
How can society reduce discrimination against fat people without denying legitimate health risks associated with obesity?
And perhaps most importantly: can people pursue better health without being told that their bodies are morally deficient?
Those are difficult questions.
They do not require accusations of fascism or genocide.
In fact, the conversation might become considerably more productive if everyone involved lowered the rhetorical temperature enough to hear the answers.
The GLP-1 revolution is not simply a story about weight loss. It is a story about medicine, capitalism, identity, autonomy and the rapidly changing relationship between bodies and technology.
That is a sufficiently important subject without turning every prescription into a political battlefield.
The controversy at Socialism 2026 may therefore be remembered less for the specific remarks than for what they exposed: a growing struggle over who gets to define what a healthy body means, who gets to decide whether a body should change, and whether individual medical choices can remain individual in an age when virtually every aspect of the body has become politically contested.
Those questions deserve serious answers.
They deserve evidence, empathy and intellectual honesty.
And above all, they deserve a debate in which people are allowed to be more than symbols of somebody else's theory.
.jpg)
.png)
0 commentaires:
Enregistrer un commentaire